Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up Tries Crowdfunding To Revive Brain Cancer Drug Berubicin

Executive Summary

Emerging Company Profile: Texas start-up CNS Pharmaceuticals sees a bright future for blood-brain barrier-crossing berubicin, which is nearing the end of its patent life.

Advertisement

Related Content

Immuno-Oncology Outlook: Looking For Brain Cancer Options
Avastin QoL Data In First-Line Glioblastoma Muddy Expansion Plans
R&D Realities Disturb Dreams About Orphan Brain Cancer Blockbusters
Recent Financings of Private Companies (09/2007)

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC123074

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel